Philip Colasante Pharmacies Pty Ltd and Australian Community Pharmacy Authority [2020] AATA 1529 (15 May 2020)
Division:GENERAL DIVISION
File Number: 2019/3674
Re:Philip Colasante Pharmacies Pty Ltd
Pharmec Pty Ltd
APPLICANTS
AndAustralian Community Pharmacy Authority
RESPONDENT
DECISION
Tribunal:Deputy President J W Constance
Date:15 May 2020
Place:Sydney
The decision under review, being the decision of the Australian Community Pharmacy Authority made 21 June 2019 to recommend that the application of Philip Colasante Pharmacies Pty Ltd and Pharmec Pty Ltd for approval to supply pharmaceutical benefits at particular premises not be approved, is affirmed.
.............................[sgd]...........................................
Deputy President J W Constance
CATCHWORDS
HEALTH - PHARMACISTS - application for approval to supply pharmaceutical benefits at premises other than premises in respect of which approval already granted - plan devised by Applicants based on National Health (Australian Community Pharmacy Authority Rules) Determination 2011 to relocate approval at expiration of two year period - National Health (Australian Community Pharmacy Authority Rules) Determination 2018 entered into force before expiration of two year period - whether Applicants can have benefit of previous Rules - whether exceptional circumstances exist - whether pharmaceutical benefits unable to be supplied at existing premises now and in the future - whether subsequent Rules offend common law presumption against retrospectivity - where subsequent Rules expressly designed to prevent establishment of temporary pharmacies which are subsequently relocated - where subsequent Rules have future effect on past events and speak only to future applications - amendment of Rules does not constitute exceptional circumstances within meaning of the Rules - inability to supply pharmaceutical benefits distinct from commercial viability of doing so - decision under review affirmed
LEGISLATION
National Health Act 1953 (Cth)
National Health (Australian Community Pharmacy Authority Rules) Determination 2018
CASES
Chang v Laidley Shire Council (2007) 234 CLR 1
Clare v Australian Community Pharmacy Authority [2015] FCA 653
Hopkins v Minister for Immigration, Citizenship, Migrant Services and Multicultural Affairs [2020] FCAFC 33Plaintiff M174/2016 v Minister for Immigration and Border Protection (2018) 264 CLR 217
REASONS FOR DECISION
Deputy President J W Constance
15 May 2020
INTRODUCTION
The approval of pharmacists to supply drugs under the Pharmaceutical Benefits Scheme is governed by the National Health Act 1953 (Cth) (the Act) and the National Health (Australian Community Pharmacy Authority Rules) Determination 2018 (the Rules).
The Applicants are approved pharmacists under the scheme and provide pharmaceutical benefits in South Australia. As part of a “strategic plan” to develop their respective businesses, the Applicants applied to the Secretary of the Department of Health for approval to supply pharmaceutical benefits at proposed premises, being different to the interim premises in respect of which approval had previously been granted. As required by the Act, the Secretary referred their application to the Australian Community Pharmacy Authority.
Having considered the application, the Authority concluded that the Applicants had not met the requirements of the Rules relating to the granting of approval. As a result, the Authority recommended to the Secretary that the application…
Keep reading for free
Create a free CaseChat account to read Philip Colasante Pharmacies Pty Ltd and Australian Community... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2020] AATA 1529
- Decision Date
CaseChat Overview and Summary
The primary legal issues before the Tribunal were whether the Applicants could benefit from the previous rules governing relocation periods, given that the rules were amended before the expiration of the two-year period, and whether exceptional circumstances existed that would justify an exception to the amended rules. The Applicants also contended that the amended rules, which increased the required period between relocations from two to five years, should not apply retrospectively to their pre-existing plan. The Tribunal was asked to determine if the inability to supply pharmaceutical benefits at the interim premises, due to its scale and location, constituted exceptional circumstances.
Deputy President Constance P reasoned that the Applicants' assumption that the law would not change was not a valid basis for their plan. The Tribunal found that the amendment to the Pharmacy Location Rules in October 2018, which increased the relocation period to five years, was expressly designed to prevent the establishment of temporary pharmacies intended for subsequent relocation. The Tribunal held that the amended rules did not offend the common law presumption against retrospectivity as they had future effect only on future applications and did not alter past events. Furthermore, the Tribunal determined that the Applicants' inability to supply pharmaceutical benefits at the interim premises was a matter of commercial viability, not an inability to supply, and therefore did not constitute exceptional circumstances within the meaning of the rules.
The Tribunal affirmed the Authority's decision of 21 June 2019, which recommended that the Applicants' application for approval to supply pharmaceutical benefits at the proposed new premises not be approved.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi